Skip to main content
. 2021 Apr 17;10(8):1748. doi: 10.3390/jcm10081748

Table 2.

Baseline characteristics of responders and impaired patients.

Responders (n = 34) Impaired (n = 11) p-Value
Age 61.00 ± 11.00 66.73 ± 7.00 0.09
Sex Ratio (H/F) 12/22 2/9 0.46
Body Mass Index (kg/m2) 26.36 ± 3.60 27.24 ± 2.98 0.44
Previous HA injection: n (%) 28 (82.0) 8 (82.0) 1
Previous PRP injection: n (%) 8 (23.5) 4 (36.4) 0.06
Volume injected 6.50 ± 1.53 6.36 ±1.57 0.40
Baseline KOOS score 35.97 ± 16.42 47.55 ± 14.07 0.02
Pain 47.59 ± 20.89 52.36 ± 16.77 0.54
Symptoms 48.74 ± 22.51 60.09 ± 16.80 0.15
ADL 48.29 ± 21.29 16.09 ± 14.62 0.27
Sport 18.85 ± 20.62 35.50 ±14.23 0.01
QOL 16.82 ± 14.05 31.90 ± 25.44 0.03
Kellgren and Lawrence scale (%)
I 17.7% 0%
II 17.7% 18.2% <0.0001
III 64.7% 36.4%
IV 0% 45.4%
MRI characteristics according ICRS classification
Proportion of patient presenting:
One compartment affected 11.5% 3.8% 0.01
Two compartments affected 49.1% 38.5%
Three compartments affected 39.3% 57.7%
Proportion of patients with at least one compart-ment presenting grade IV OA: 46.7% 73.0% 0.17
Pain at the injection (VAS) 27.88 ± 27.36 32.73 ± 24.12 0.55

HA: hyaluronic acid, PRP: Platelet-rich plasma, ADL: activities of daily living, QOL: quality of life.